These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14764889)

  • 1. Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation.
    Antoch G; Kuehl H; Kanja J; Lauenstein TC; Schneemann H; Hauth E; Jentzen W; Beyer T; Goehde SC; Debatin JF
    Radiology; 2004 Mar; 230(3):879-85. PubMed ID: 14764889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water-equivalent oral contrast agents in dual-modality PET/computed tomography scanning: does a little barium make the difference?
    Kinner S; Veit-Haibach P; Lauenstein TC; Bockisch A; Antoch G
    Nucl Med Commun; 2009 Mar; 30(3):206-9. PubMed ID: 19262282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose optimization of mannitol solution for small bowel distension in MRI.
    Ajaj W; Goehde SC; Schneemann H; Ruehm SG; Debatin JF; Lauenstein TC
    J Magn Reson Imaging; 2004 Oct; 20(4):648-53. PubMed ID: 15390230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of oral contrast agents for MR imaging of the small bowel.
    Lauenstein TC; Schneemann H; Vogt FM; Herborn CU; Ruhm SG; Debatin JF
    Radiology; 2003 Jul; 228(1):279-83. PubMed ID: 12750457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of low-density neutral oral contrast material in PET/CT for tumor imaging: results of a randomized clinical trial.
    Otero HJ; Yap JT; Patak MA; Erturk SM; Israel DA; Johnston CJ; Sakellis C; Rybicki FJ; Van den Abbeele AD; Ros PR
    AJR Am J Roentgenol; 2009 Aug; 193(2):326-32. PubMed ID: 19620427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT.
    Nehmeh SA; Erdi YE; Kalaigian H; Kolbert KS; Pan T; Yeung H; Squire O; Sinha A; Larson SM; Humm JL
    J Nucl Med; 2003 Dec; 44(12):1940-4. PubMed ID: 14660720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydro-MRI of the small bowel: effect of contrast volume, timing of contrast administration, and data acquisition on bowel distention.
    Kuehle CA; Ajaj W; Ladd SC; Massing S; Barkhausen J; Lauenstein TC
    AJR Am J Roentgenol; 2006 Oct; 187(4):W375-85. PubMed ID: 16985108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small bowel hydro-MR imaging for optimized ileocecal distension in Crohn's disease: should an additional rectal enema filling be performed?
    Ajaj W; Lauenstein TC; Langhorst J; Kuehle C; Goyen M; Zoepf T; Ruehm SG; Gerken G; Debatin JF; Goehde SC
    J Magn Reson Imaging; 2005 Jul; 22(1):92-100. PubMed ID: 15971189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contrast agents for small bowel distension in MRI: influence of the osmolarity for small bowel distention.
    Ajaj W; Goyen M; Schneemann H; Kuehle C; Nuefer M; Ruehm SG; Goehde SC; Lauenstein TC
    Eur Radiol; 2005 Jul; 15(7):1400-6. PubMed ID: 15754160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materials.
    Antoch G; Freudenberg LS; Stattaus J; Jentzen W; Mueller SP; Debatin JF; Bockisch A
    AJR Am J Roentgenol; 2002 Dec; 179(6):1555-60. PubMed ID: 12438054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bowel hot spots at PET-CT.
    Prabhakar HB; Sahani DV; Fischman AJ; Mueller PR; Blake MA
    Radiographics; 2007; 27(1):145-59. PubMed ID: 17235004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contrast agents for small bowel MRI: comparison of different additives to optimize bowel distension.
    Ajaj W; Goehde SC; Schneemann H; Ruehm SG; Debatin JF; Lauenstein TC
    Eur Radiol; 2004 Mar; 14(3):458-64. PubMed ID: 14634782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT.
    Antoch G; Freudenberg LS; Beyer T; Bockisch A; Debatin JF
    J Nucl Med; 2004 Jan; 45 Suppl 1():56S-65S. PubMed ID: 14736836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images.
    Baek CH; Chung MK; Son YI; Choi JY; Kim HJ; Yim YJ; Ko YH; Choi J; Cho JK; Jeong HS
    J Nucl Med; 2008 Sep; 49(9):1422-8. PubMed ID: 18703597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different intravenous contrast media concentrations do not affect clinical assessment of 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans in an intraindividual comparison.
    Prechtel HW; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM; Behrendt FF
    Invest Radiol; 2012 Sep; 47(9):497-502. PubMed ID: 22820678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging.
    Brechtel K; Klein M; Vogel M; Mueller M; Aschoff P; Beyer T; Eschmann SM; Bares R; Claussen CD; Pfannenberg AC
    J Nucl Med; 2006 Mar; 47(3):470-6. PubMed ID: 16513616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imaging.
    Antoch G; Jentzen W; Freudenberg LS; Stattaus J; Mueller SP; Debatin JF; Bockisch A
    Invest Radiol; 2003 Dec; 38(12):784-9. PubMed ID: 14627896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial experience with oral contrast in PET/CT: phantom and clinical studies.
    Cohade C; Osman M; Nakamoto Y; Marshall LT; Links JM; Fishman EK; Wahl RL
    J Nucl Med; 2003 Mar; 44(3):412-6. PubMed ID: 12621008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners.
    Kinahan PE; Hasegawa BH; Beyer T
    Semin Nucl Med; 2003 Jul; 33(3):166-79. PubMed ID: 12931319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiphase CT scanning and different intravenous contrast media concentrations in combined F-18-FDG PET/CT: Effect on quantitative and clinical assessment.
    Rebière M; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM; Behrendt FF
    Eur J Radiol; 2012 Aug; 81(8):e862-9. PubMed ID: 22591760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.